<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Dermatol</journal-id><journal-id journal-id-type="iso-abbrev">Int J Dermatol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>International journal of dermatology</journal-title></journal-title-group><issn pub-type="ppub">0011-9059</issn><issn pub-type="epub">1365-4632</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10835602</article-id><article-id pub-id-type="pmcid-ver">PMC10835602.1</article-id><article-id pub-id-type="pmcaid">10835602</article-id><article-id pub-id-type="pmcaiid">10835602</article-id><article-id pub-id-type="manuscript-id">NIHMS1800644</article-id><article-id pub-id-type="pmid">35485975</article-id><article-id pub-id-type="doi">10.1111/ijd.16228</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1800644</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1800644</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Comorbid Diseases of Hidradenitis Suppurativa: A 15-Year Population-Based Study in Olmsted County, Minnesota, USA</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sokumbi</surname><given-names initials="O">Olayemi</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hodge</surname><given-names initials="DO">David O.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ederaine</surname><given-names initials="SA">Sophia A.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alavi</surname><given-names initials="A">Afsaneh</given-names></name><degrees>MD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alikhan</surname><given-names initials="AM">Ali M.</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Departments of Dermatology and Laboratory Medicine &amp; Pathology, Mayo Clinic, Jacksonville, FL</aff><aff id="A2"><label>2</label>Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL</aff><aff id="A3"><label>3</label>Student, Mayo Clinic Alix School of Medicine, Arizona Campus, Scottsdale, AZ,</aff><aff id="A4"><label>4</label>Department of Dermatology, Mayo Clinic, Rochester, MN</aff><aff id="A5"><label>5</label>Department of Dermatology, Sutter Medical Foundation, Sacramento, CA</aff><author-notes><corresp id="CR1"><bold>Corresponding author:</bold> Olayemi Sokumbi, MD, Departments of Dermatology and Laboratory Medicine &amp; Pathology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224. (<email>sokumbi.olayemi@mayo.edu</email>).</corresp><fn fn-type="COI-statement" id="FN1"><p id="P33">Conflict of Interest Disclosure: None</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>29</day><month>4</month><year>2022</year></pub-date><volume>61</volume><issue>11</issue><issue-id pub-id-type="pmc-issue-id">454905</issue-id><fpage>1372</fpage><lpage>1379</lpage><pub-history><event event-type="nihms-submitted"><date><day>28</day><month>12</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>02</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>02</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-22 17:25:33.850"><day>22</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1800644.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Like other chronic, inflammatory skin disorders, hidradenitis suppurativa (HS) is increasingly recognized to be associated with various medical disorders.</p></sec><sec id="S2"><title>Objective:</title><p id="P2">Using the Rochester Epidemiology Project (REP), we sought to conduct the first American population-based study examining the association between HS and various comorbid conditions.</p></sec><sec id="S3"><title>Methods:</title><p id="P3">From the REP database we identified patients diagnosed with HS from 2003 through 2018 who were residents of Olmsted County, Minnesota, USA, along with age- and sex-matched controls. The frequency of a wide variety of comorbid conditions was compared between the groups.</p></sec><sec id="S4"><title>Results:</title><p id="P4">A total of 1,160 patients with HS were identified during the study period. Compared with age- and sex-matched controls, patients with HS had a significantly higher frequency of several medical conditions, including depression, anxiety, hyperlipidemia, acne conglobata, dissecting cellulitis, pilonidal cysts, polycystic ovary syndrome, diabetes, chronic kidney disease, psoriasis, atopic dermatitis, obesity, and disordered substance use, among others.</p></sec><sec id="S5"><title>Limitations:</title><p id="P5">Our study was limited by its retrospective design.</p></sec><sec id="S6"><title>Conclusions:</title><p id="P6">Providers caring for patients with HS should consider these results, along with those of similar studies, and obtain a thorough history, comprehensive physical examination, and, potentially, laboratory testing and referral to other specialists.</p></sec></abstract><kwd-group><kwd>acne inversa</kwd><kwd>autoinflammatory disorders</kwd><kwd>comorbid conditions</kwd><kwd>follicular occlusion</kwd><kwd>hidradenitis suppurativa</kwd><kwd>screening</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>